Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Abo

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 5, 2011
Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomicsKendra K S Nordgren, Yi Peng, Linda L Pelleymounter, et al.
Molecular Genetics and Metabolism|November 25, 2010
Betaine-homocysteine methyltransferase: human liver genotype-phenotype correlationQiping Feng, Krishna Kalari, Brooke L Fridley, et al.
Plos One|August 13, 2013
Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinomaKatarzyna A Ellsworth, Bruce W Eckloff, Liang Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2011
Fine-mapping CASP8 risk variants in breast cancerNicola J Camp, Marina Parry, Stacey Knight, et al.
Pharmacogenetics and Genomics|January 18, 2013
FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorderKatarzyna A Ellsworth, Irene Moon, Bruce W Eckloff, et al.
Cell|January 29, 2013
Braveheart, a long noncoding RNA required for cardiovascular lineage commitmentCarla A Klattenhoff, Johanna C Scheuermann, Lauren E Surface, et al.
Pharmacogenetics and Genomics|February 11, 2012
Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomicsRyan Abo, Scott Hebbring, Yuan Ji, et al.
Cancer Research|March 26, 2009
A breast cancer risk haplotype in the caspase-8 geneNeil Duncan Shephard, Ryan Abo, Sushila Harkisandas Rigas, et al.
Chembiochem : a European Journal of Chemical Biology|April 10, 2021
Targeted Degradation of PARP14 Using a Heterobifunctional Small MoleculeTim J Wigle, Yue Ren, Jennifer R Molina, et al.
Cell Chemical Biology|March 11, 2021
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explantsLaurie B Schenkel, Jennifer R Molina, Kerren K Swinger, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 5, 2011
Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomicsKendra K S Nordgren, Yi Peng, Linda L Pelleymounter, et al.
Molecular Genetics and Metabolism|November 25, 2010
Betaine-homocysteine methyltransferase: human liver genotype-phenotype correlationQiping Feng, Krishna Kalari, Brooke L Fridley, et al.
Plos One|August 13, 2013
Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinomaKatarzyna A Ellsworth, Bruce W Eckloff, Liang Li, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2011
Fine-mapping CASP8 risk variants in breast cancerNicola J Camp, Marina Parry, Stacey Knight, et al.
Pharmacogenetics and Genomics|January 18, 2013
FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorderKatarzyna A Ellsworth, Irene Moon, Bruce W Eckloff, et al.
Cell|January 29, 2013
Braveheart, a long noncoding RNA required for cardiovascular lineage commitmentCarla A Klattenhoff, Johanna C Scheuermann, Lauren E Surface, et al.
Pharmacogenetics and Genomics|February 11, 2012
Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomicsRyan Abo, Scott Hebbring, Yuan Ji, et al.
Cancer Research|March 26, 2009
A breast cancer risk haplotype in the caspase-8 geneNeil Duncan Shephard, Ryan Abo, Sushila Harkisandas Rigas, et al.
Chembiochem : a European Journal of Chemical Biology|April 10, 2021
Targeted Degradation of PARP14 Using a Heterobifunctional Small MoleculeTim J Wigle, Yue Ren, Jennifer R Molina, et al.
Cell Chemical Biology|March 11, 2021
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explantsLaurie B Schenkel, Jennifer R Molina, Kerren K Swinger, et al.
Pageof 3